DaVita launches Kidney Awareness Run|Walks for chronic kidney disease

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today announced its launch of the 5th annual DaVita Kidney Awareness Run|Walks™ - a 10-city series of 5K events raising funds and awareness of CKD across the nation.

“Working with DaVita as a team moving toward a common goal, we can get the word out about the prevalence of the disease and the importance of getting tested right now.”

The run|walks kicked off in Chicago on Sept. 11 and will also take place in Cincinnati; Cleveland; St. Louis; Washington, D.C.; Virginia Beach, Va.; Ft. Worth, Texas; Sacramento and Long Beach, Calif.

A silent epidemic, CKD affects one in six Americans, totaling around 31 million adults, with most unaware they are suffering from it. The chance that an American adult has CKD is 12 times greater than an American woman's risk of getting breast cancer. The Centers for Disease Control and Prevention recognize CKD as a major public health problem that reduces the quality and length of life.

"The statistics are staggering," said Annette Eros, president and CEO of The Kidney TRUST™. "Working with DaVita as a team moving toward a common goal, we can get the word out about the prevalence of the disease and the importance of getting tested right now."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients